A study for a 40 year old woman who takes Gabapentin, Cyclobenzaprine Hydrochloride - from FDA reports


Summary

871 females aged 40 (±5) who take the same drugs are studied. This is a personalized study for a 40 year old female patient who has Pain, Sciatica. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 30, 2017

871 females aged 40 (±5) who take Gabapentin, Cyclobenzaprine Hydrochloride are studied.


Number of reports submitted per year:

Gabapentin, Cyclobenzaprine Hydrochloride for a 40-year old woman.

Information of the patient in this study:

  • Age: 40
  • Gender: female
  • Conditions: Pain, Sciatica
  • Drugs taken:
    • Gabapentin (gabapentin)
    • Cyclobenzaprine Hydrochloride (cyclobenzaprine hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Discoid Lupus Erythematosus Aggravated: 0 (0% of females aged 40 (±5) who take the drugs)
  • Intracranial Pressure - Increased: 0 (0% of females aged 40 (±5) who take the drugs)
  • Lightheadedness: 1 (0.11% of females aged 40 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • drug ineffective
  • weight increased
  • erythema multiforme
  • dizziness
  • weakness
  • nausea
  • nausea and vomiting
  • indigestion
  • wound
  • abdominal pain
1 - 6 months:
  • malaise
  • constipation
  • blood glucose increased
  • nausea and vomiting
  • tremor
  • appetite - decreased
  • nausea
  • breast cancer
  • high blood cholesterol
  • serum ferritin decreased
6 - 12 months:
  • hyperthyroidism
  • intervertebral disc protrusion
  • incontinence
  • anaemia
  • exostosis
  • post-traumatic stress disorder
  • cataplexy
  • stress and anxiety
  • suicidal ideation
  • pulmonary infarction
1 - 2 years:
  • overdose
  • acute respiratory failure
  • deep venous thrombosis
  • pulmonary embolism
  • mental disorder
  • injury
  • breast cancer
  • respiratory acidosis
  • stress and anxiety
  • fatigue
2 - 5 years:
  • stress and anxiety
  • autoimmune disorder
  • drug ineffective
  • kidney stones
  • depression
  • gastroesophageal reflux disease
  • chronic thyroiditis
  • sjogren syndrome
  • hyperthyroidism
  • abdominal discomfort
5 - 10 years:
  • drowsiness
  • panic disorder
  • mental impairment
  • stress and anxiety
  • blood glucose fluctuation
  • swelling
  • vision blurred
  • thirst
  • cognitive disorder
  • confusional state
10+ years:
  • neurosis
  • thinking abnormal
not specified:
  • nausea
  • depression
  • stress and anxiety
  • fatigue
  • breathing difficulty
  • headache
  • weakness
  • pain in extremity
  • chest pain
  • drug ineffective

Top conditions involved for these people *:

  • Depression (121 people, 13.89%)
  • Stress And Anxiety (80 people, 9.18%)
  • Multiple Sclerosis (74 people, 8.50%)
  • Rheumatoid Arthritis (61 people, 7.00%)
  • Sleep Disorder (43 people, 4.94%)

Top co-used drugs for these people *:

  • Ambien (113 people, 12.97%)
  • Xanax (109 people, 12.51%)
  • Cymbalta (99 people, 11.37%)
  • Nexium (97 people, 11.14%)
  • Klonopin (91 people, 10.45%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

  • Discoid lupus erythematosus aggravated (chronic skin condition of sores with inflammation and scarring favouring the face, ears, and scalp-aggravated) has been reported by people with unevaluable reaction, rheumatoid arthritis, high blood pressure, systemic lupus erythematosus, atrial fibrillation/flutter (latest reports from 13 Discoid lupus erythematosus aggravated patients).
  • Intracranial pressure - increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid) has been reported by people with herniated nucleus pulposus (slipped disk), urinary tract infection, musculoskeletal pain, allergies, insomnia (latest reports from 26 Intracranial pressure - increased patients).
  • Lightheadedness (a common and often unpleasant sensation of dizziness and/or feeling that one may be about to faint) has been reported by people with high blood pressure, multiple sclerosis, depression, osteoporosis, pain (latest reports from 302,913 Lightheadedness patients).

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Pain, Lightheadedness, Cyclobenzaprine hydrochloride, Sciatica, Discoid lupus erythematosus aggravated, Intracranial pressure - increased, Gabapentin

You may be interested in these reviews

More reviews for: Pain, Lightheadedness, Cyclobenzaprine hydrochloride, Sciatica, Discoid lupus erythematosus aggravated, Intracranial pressure - increased, Gabapentin